The Global Health Body Sounds Concern Over Severe Scarcity of Weight-Loss Jabs
Less than a tenth of people eligible to benefit from GLP-1 drugs such as Wegovy are able to get them, caution the global health agency as it publishes its first advice on the drugs.
Given in excess of 1,000,000,000 people worldwide now classified as obese, it is urging increased and just availability to this class of drugs.
Per estimates, over two billion could be living with obesity by 2030 unless action is taken.
"Our latest guidelines acknowledges that excess weight is a long-term condition that can be treated with thorough and lifelong care," remarked its chief Tedros Adhanom Ghebreyesus.
Significant expense, constrained manufacturing, and distribution challenges are key hurdles to universal availability to the treatments that can aid individuals in losing significant body mass, notes the body.
Weight-Loss Drug Scarcity
Even under the current most favorable scenario, the manufacturing of GLP-1 therapies would only suffice for around 100 million people – less than 10% of the global need, per the health organization.
The advice urges countries and companies to increase access, by strategies such as licensing agreements.
The intellectual property rights on the active ingredient – the core ingredient of a leading brand – is due to expire in a number of nations in 2026.
How Obesity Jabs Operate
The injections replicate a natural hormone to reduce digestion speed, suppress the appetite and increase the sense of being full so individuals consume fewer calories.
People typically see weight reduction within a few weeks of commencing the regular doses.
Research points to patients may put most of the weight back on after a year of stopping the medication, as their usual appetite return.
To be carrying excess weight increases your chance for developing diseases, such as diabetes, cardiovascular issues, brain attack, and specific cancers.
Obesity concerns people in all nations and was responsible for millions of deaths worldwide in 2024, as per the WHO.
